Dordaviprone
| CAS No. | 1616632-77-9 |
|---|---|
| MDL No. | MFCD28118993 |
| MF | C24H26N4O |
| MW | 386.50 |
| InChI Key | VLULRUCCHYVXOH-UHFFFAOYSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Dordaviprone is an organic heterotricyclic compound, specifically 2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, substituted with 2-methylbenzyl at position 4 and benzyl at position 7. It acts as a selective dopamine receptor D2 antagonist and an allosteric agonist of mitochondrial protease caseinolytic protease P. It functions as an antineoplastic agent, dopamine receptor D2 antagonist, and apoptosis inducer. It belongs to toluenes, benzenes, and organic heterotricyclic compounds.
| CAS No. | 1616632-77-9 |
|---|---|
| Product Name | Dordaviprone |
Associated Conditions
glioblastoma multiforme·endometrial cancer·myelodysplastic syndrome·neoplasm·meningioma·
* The information provided here is compiled from public sources and is for reference only.
